Maud Déruaz

1.8k total citations
22 papers, 1.4k citations indexed

About

Maud Déruaz is a scholar working on Immunology, Virology and Epidemiology. According to data from OpenAlex, Maud Déruaz has authored 22 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 10 papers in Virology and 7 papers in Epidemiology. Recurrent topics in Maud Déruaz's work include HIV Research and Treatment (10 papers), Immune Cell Function and Interaction (7 papers) and Invertebrate Immune Response Mechanisms (4 papers). Maud Déruaz is often cited by papers focused on HIV Research and Treatment (10 papers), Immune Cell Function and Interaction (7 papers) and Invertebrate Immune Response Mechanisms (4 papers). Maud Déruaz collaborates with scholars based in United States, Switzerland and Brazil. Maud Déruaz's co-authors include Andrew D. Luster, Andrew M. Tager, Vladimir Vrbanac, Amanda E. I. Proudfoot, Edward Seung, Christopher Power, Thomas T. Murooka, Mauro Martins Teixeira, Thorsten R. Mempel and Timothy N. C. Wells and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Maud Déruaz

22 papers receiving 1.4k citations

Peers

Countries citing papers authored by Maud Déruaz

Since Specialization

Citations

This map shows the geographic impact of Maud Déruaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maud Déruaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maud Déruaz more than expected).

Fields of papers citing papers by Maud Déruaz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maud Déruaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maud Déruaz. The network helps show where Maud Déruaz may publish in the future.

Co-authorship network of co-authors of Maud Déruaz

This figure shows the co-authorship network connecting the top 25 collaborators of Maud Déruaz. A scholar is included among the top collaborators of Maud Déruaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maud Déruaz. Maud Déruaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Intra- and extra-cellular environments contribute to the fate of HIV-1 infection 2021 ·Cell Reports ·(unknown), (unknown), (unknown), Zachary T. Herbert, Vladimir Vrbanac, Maud Déruaz, Vasudevan Achuthan, Alan Engelman, Joseph Sodroski, Alon Herschhorn	17
2	Poly I:C and STING agonist‐primed DC increase lymphoid tissue polyfunctional HIV‐1‐specific CD8 ⁺ T cells and limit CD4 ⁺ T‐cell loss in BLT mice 2021 ·European Journal of Immunology ·(unknown), Daniel T. Claiborne, Maud Déruaz, (unknown), Carla Serra, (unknown), Ildefonso Sánchez‐Cerrillo, Ignacio de los Santos, Jesús Sanz, Lucio García‐Fraile, Francisco Sánchez‐Madrid, Arántzazu Alfranca, María Ángeles Muñoz‐Fernández, Todd M. Allen, María J. Buzón, Alejandro B. Balazs, Vladimir Vrbanac, Enrique Martín‐Gayo	12
3	An injectable bone marrow–like scaffold enhances T cell immunity after hematopoietic stem cell transplantation 2019 ·Nature Biotechnology ·Nisarg J. Shah, Angelo S. Mao, Ting‐Yu Shih, (unknown), Azeem Sharda, Theresa M. Raimondo, James Weaver, Vladimir Vrbanac, Maud Déruaz, Andrew M. Tager, David Mooney, David T. Scadden	84
4	HIV-1 Balances the Fitness Costs and Benefits of Disrupting the Host Cell Actin Cytoskeleton Early after Mucosal Transmission 2019 ·Cell Host & Microbe ·Shariq M. Usmani, Thomas T. Murooka, Maud Déruaz, Wan Hon Koh, Radwa Sharaf, Mauro Di Pilato, Karen A. Power, (unknown), (unknown), Vladimir Vrbanac, Andrew M. Tager, Todd M. Allen, Andrew D. Luster, Thorsten R. Mempel	17
5	HIV-1 and SIV Infection Are Associated with Early Loss of Lung Interstitial CD4+ T Cells and Dissemination of Pulmonary Tuberculosis 2019 ·Cell Reports ·Björn Corleis, Allison N. Bucşan, Maud Déruaz, Vladimir Vrbanac, (unknown), (unknown), (unknown), Jeffrey M. Paer, Gregory S. Olson, Brittany A. Bowman, Abigail E. Schiff, Benjamin D. Medoff, Andrew M. Tager, Andrew D. Luster, Shabaana A. Khader, Deepak Kaushal, Douglas S. Kwon	28
6	A knottin scaffold directs the CXC-chemokine–binding specificity of tick evasins 2019 ·Journal of Biological Chemistry ·Angela Lee, Maud Déruaz, (unknown), Graham Davies, (unknown), (unknown), (unknown), Akane Kawamura, Jeffrey P. Shaw, Amanda E. I. Proudfoot, (unknown), Shoumo Bhattacharya	25
7	Humanized mouse models of latent HIV infection 2017 ·Current Opinion in Virology ·Maud Déruaz, Andrew M. Tager	12
8	Chemoattractant-mediated leukocyte trafficking enables HIV dissemination from the genital mucosa 2017 ·JCI Insight ·Maud Déruaz, Thomas T. Murooka, (unknown), Marc A. Gavin, Vladimir Vrbanac, Judy Lieberman, Andrew M. Tager, Thorsten R. Mempel, Andrew D. Luster	15
9	Protection of Humanized Mice From Repeated Intravaginal HIV Challenge by Passive Immunization: A Model for Studying the Efficacy of Neutralizing Antibodies In Vivo 2016 ·The Journal of Infectious Diseases ·Maud Déruaz, Brian Moldt, Khoa Le, Karen A. Power, Vladimir Vrbanac, (unknown), Musie Ghebremichael, Todd M. Allen, Andrew M. Tager, Dennis R. Burton, Andrew D. Luster	35
10	Chemokine‐mediated immune responses in the female genital tract mucosa 2015 ·Immunology and Cell Biology ·Maud Déruaz, Andrew D. Luster	24
11	IL-21 induces antiviral microRNA-29 in CD4 T cells to limit HIV-1 infection 2015 ·Nature Communications ·Stanley Adoro, Juan R. Cubillos‐Ruiz, Xi Chen, Maud Déruaz, Vladimir Vrbanac, Minkyung Song, (unknown), Thomas T. Murooka, Timothy Dudek, Andrew D. Luster, Andrew M. Tager, Hendrik Streeck, Brittany A. Bowman, Bruce D. Walker, Douglas S. Kwon, Vanja Lazarevic, Laurie H. Glimcher	62
12	Evasin‐4, a tick‐derived chemokine‐binding protein with broad selectivity can be modified for use in preclinical disease models 2013 ·FEBS Journal ·Maud Déruaz, Pauline Bonvin, (unknown), Zoë Johnson, Sonja Krohn, Christopher Power, Amanda E. I. Proudfoot	35
13	HIV-infected T cells are migratory vehicles for viral dissemination 2012 ·Nature ·Thomas T. Murooka, Maud Déruaz, Francesco Marangoni, Vladimir Vrbanac, Edward Seung, Ulrich H. von Andrian, Andrew M. Tager, Andrew D. Luster, Thorsten R. Mempel	247
14	Treatment with Evasin-3 Reduces Atherosclerotic Vulnerability for Ischemic Stroke, but Not Brain Injury in Mice 2012 ·Journal of Cerebral Blood Flow & Metabolism ·Jean‐Christophe Copin, Rafaela da Silva, Luciano dos Santos Aggum Capettini, (unknown), Sébastien Lenglet, Graziano Pelli, Katia Galan, Fabienne Burger, Vincent Braunersreuther, Karl Schaller, Maud Déruaz, Amanda Proudfoot, Franco Dallegri, Nikolaos Stergiopulos, Robson A.S. Santos, Yvan Gasche, François Mach, Fabrizio Montecucco, (unknown)	56
15	Inhibition of HIV transmission in human cervicovaginal explants and humanized mice using CD4 aptamer-siRNA chimeras 2011 ·Journal of Clinical Investigation ·Lee Adam Wheeler, Radiana Trifonova, Vladimir Vrbanac, Emre Basar, (unknown), Zhan Xu, Edward Seung, Maud Déruaz, (unknown), (unknown), Linda Yang, Todd M. Allen, Andrew D. Luster, Andrew M. Tager, Derek M. Dykxhoorn, Judy Lieberman	184
16	Treatment with a Novel Chemokine-Binding Protein or Eosinophil Lineage-Ablation Protects Mice from Experimental Colitis 2009 ·American Journal Of Pathology ·Angélica T. Vieira, Caio T. Fagundes, Ana L. Alessandri, Marina Gomes Miranda e Castor, Rodrigo Guabiraba, (unknown), Kátia D. Silveira, Érica Leandro Marciano Vieira, (unknown), Tarcı́lia Aparecida Silva, Maud Déruaz, Amanda E. I. Proudfoot, Lirlândia P. Sousa, Mauro Martins Teixeira	78
17	Structural Basis of Chemokine Sequestration by a Tick Chemokine Binding Protein: The Crystal Structure of the Complex between Evasin-1 and CCL3 2009 ·PLoS ONE ·(unknown), Christophe Losberger, Maud Déruaz, Christopher Power, Amanda E. I. Proudfoot, Jeffrey P. Shaw	44
18	Ticks produce highly selective chemokine binding proteins with antiinflammatory activity 2008 ·The Journal of Experimental Medicine ·Maud Déruaz, (unknown), Ana L. Alessandri, (unknown), Fernanda M. Coelho, Remo Castro Russo, Beatriz Rossetti Ferreira, Gerard J. Graham, Jeffrey P. Shaw, Timothy N. C. Wells, Mauro Martins Teixeira, Christopher Power, Amanda E. I. Proudfoot	168
19	An engineered monomer of CCL2 has anti-inflammatory properties emphasizing the importance of oligomerization for chemokine activity in vivo 2008 ·Journal of Leukocyte Biology ·Tracy M. Handel, Zoë Johnson, David Henrique Rodrigues, Adriana Santos, R Cirillo, Valeria Muzio, (unknown), Matthias Mack, Maud Déruaz, Frédéric Borlat, Pierre‐Alain Vitte, Timothy N. C. Wells, Mauro Martins Teixeira, Amanda E. I. Proudfoot	58
20	Molecular Cloning and Characterization of a Highly Selective Chemokine-binding Protein from the Tick Rhipicephalus sanguineus 2007 ·Journal of Biological Chemistry ·(unknown), Christopher Power, Maud Déruaz, Beatriz Rossetti Ferreira, João S. Silva, Mauro Martins Teixeira, (unknown), Thierry Martin, Timothy N. C. Wells, Amanda E. I. Proudfoot	103

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact